
Alkem Laboratories (ALKEM) Share Price Rises 2.5% as Stock Hits Rs 5,394.40
Updated: 7 Oct 2026 • 10:32 am
Posted by:

Alkem Laboratories Share Price is Rs 5,394.40, up 2.5% today, and the company’s market capitalisation stands at Rs 61,825.27 Cr. The move places Alkem Laboratories Share Price among the notable rising names in the healthcare space today, with the stock trading above its previous close and holding near the upper part of its day’s range. According to latest Univest figures, the price event is confirmed through the intraday move itself, while the broader reading comes from valuation, profitability and sector comparison. Alkem Laboratories Share Price today is therefore relevant not just as a price-rise event, but as a live market signal that can be read alongside its earnings quality, returns profile and industry position. Investors tracking Alkem Laboratories Share Price can watch how the stock behaves against its day high, peer valuation and healthcare benchmark through the rest of the trading session.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,394.4 |
| Previous Close | Rs 5,262.9 |
| Today's Move | Rs 131.5 (+2.5%) |
| Open | Rs 5,347.95 |
| High | Rs 5,400 |
| Low | Rs 5,297 |
| Market Capitalisation | Rs 61,825.27 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Ltd. (ALKEM) rose to Rs 5,394.4 from the previous close of Rs 5,262.9, a move of Rs 131.5 or 2.5%. The stock opened at Rs 5,347.95, reached a high of Rs 5,400, recorded a low of Rs 5,297.
Alkem Laboratories Share Price today reflects a clear intraday rise. The stock last traded at Rs 5,394.40 versus the previous close of Rs 5,262.90, a gain of Rs 131.50 or 2.5%. It opened at Rs 5,347.95, moved between Rs 5,297 and Rs 5,400, and was trading close to the day high as of 07 October 2026 at 10:22:41 AM IST. That price action keeps Alkem Laboratories Share Price firmly in the day’s top-moving zone without requiring any outside explanation. The stock’s market capitalisation of Rs 61,825.27 Cr also places the move in a large absolute value context. For readers following Alkem Laboratories Share Price Today, the key point is straightforward: the stock has moved higher in a defined range, with the current level still above the previous close and near the session high. The next layer is fundamental analysis, which adds valuation and quality context to this price rise.
Why Alkem Laboratories Ltd. (ALKEM) May Be Moving Today
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 61,825.27 crore |
| P/E Ratio | 29.17x |
| P/B Ratio | 4.4x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.01% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 29.17x, P/B 4.4x, ROE 18.29%, ROCE 21.28%. These ratios show where the company stands today and are not a call to buy or sell.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 29.17x |
| Benchmark Median P/E | 32.15x |
| Benchmark Average P/E | 48.45x |
| Benchmark P/E Range | 3.58x to 695.67x |
| Company P/B Ratio | 4.4x |
| Benchmark Median P/B | 2.96x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 61,825.27 crore |
| Benchmark Median Market Cap | Rs 816.35 crore |
Alkem Laboratories Ltd. (ALKEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 29.17x, which is below the benchmark median of 32.15x, a difference of -9.27%. A P/E difference of this kind is a reference point rather than a recommendation.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.73%, a difference of +55.92%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.63%, a difference of +56.13%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,27,561.49 | 35.73 | 5 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,572.22 | 86.63 | 14.35 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,80,870.62 | 83.33 | 20.25 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,13,565.81 | 25.64 | 4.29 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,07,769.94 | 32.19 | 3.09 | 11.83 | 16 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 29.17x compared with the displayed peer median of 35.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 61,825.27 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price rose 2.5% today and is trading near the day high, which keeps price action central to the discussion.
- Alkem Laboratories Share Price is backed by ROE of 18.29% and ROCE of 21.28%, both above the same-industry benchmark medians.
- Alkem Laboratories Share Price trades at a P/E of 29.17, below the industry median of 32.15 and well below the industry average of 48.45.
- Alkem Laboratories Share Price has a P/B ratio of 4.4, with valuation support coming from EPS of Rs 180.45 and book value of Rs 1,196.51.
- Alkem Laboratories Share Price is being tracked against healthcare peers where return ratios and market cap comparisons remain relevant.
About Alkem Laboratories
Alkem Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical products and related healthcare offerings, and its market position is reflected in a market capitalisation of Rs 61,825.27 Cr. Alkem Laboratories Share Price therefore represents a well-established listed healthcare name rather than a narrow niche business. The latest Univest figures place it in a broad industry set that includes large Indian drug makers and specialty peers. In this context, Alkem Laboratories Share Price is influenced by company financials, valuation multiples and return ratios more than by a simple size label. The stock’s business background matters because pharmaceutical companies are typically evaluated through revenue quality, profitability, capital efficiency and relative valuation. That makes Alkem Laboratories Share Price a useful case study for investors comparing healthcare names on fundamentals, not only on daily price moves.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price is Rs 5,394.40, up 2.5% from the previous close of Rs 5,262.90. The stock is trading near the day high, which places the move firmly in today’s price action discussion.
Why is Alkem Laboratories Share Price rising today?
Ans. Alkem Laboratories Share Price is higher today after an intraday move from Rs 5,262.90 to Rs 5,394.40.
What is the market cap of Alkem Laboratories?
Ans. Alkem Laboratories has a market capitalisation of Rs 61,825.27 Cr. That figure helps place Alkem Laboratories Share Price in a large-company valuation context and is useful when comparing the stock with pharmaceutical peers.
How does Alkem Laboratories Share Price look on valuation?
Ans. Alkem Laboratories Share Price carries a P/E of 29.17 and a P/B of 4.4. The P/E is below the same-industry median of 32.15, while the P/B is slightly above the industry average of 4.32.
Is Alkem Laboratories profitable on return ratios?
Ans. Alkem Laboratories shows ROE of 18.29% and ROCE of 21.28%. Both figures are above the same-industry median and average, which adds quality context to Alkem Laboratories Share Price today.
What do EPS and book value say about Alkem Laboratories Share Price?
Ans. EPS is Rs 180.45 and book value is Rs 1,196.51. EPS shows earnings attributable to each share, while book value shows accounting net worth per share, both of which support fundamental analysis of Alkem Laboratories Share Price.
How does Alkem Laboratories compare with healthcare peers?
Ans. Alkem Laboratories Share Price has a smaller market cap than Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd. and Torrent Pharmaceuticals Ltd., but its P/E is lower than several of those peers and its ROCE remains competitive.
What is the dividend yield for Alkem Laboratories?
Ans. Alkem Laboratories has a dividend yield of 1.01%. Dividend yield is a historical and current payout measure, so it complements Alkem Laboratories Share Price analysis but does not guarantee future distributions.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Alkem Laboratories Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights. Alkem Laboratories Share Price Today can also be reviewed alongside market cap, P/E, P/B, ROE, ROCE, EPS and book value in one place. For readers following Alkem Laboratories Stock Analysis, the platform keeps the price move, valuation context and sector comparison together.
Recent Articles

Kalyan Jewellers Share Price Rally: Stock Gains About 42% in 11 Sessions After Rs 427 Crore Q2 Profit, Hits Near Two-Year High and Trades at Rs 708.15 on 16 November 2026 as UBS and Jefferies Raise Targets
16 November 2026

Tata Motors PV vs Eicher Motors After Q2: TMPV Falls 8.7% to Rs 262 on a Rs 5,451 Crore Loss and JLR Guidance Cut While Eicher Posts Record Revenue and a 15% Profit Rise
16 November 2026

Belrise Industries Share Price Jumps 9% to Rs 235 After Q2 PAT Rises 25%: Fresh H-One India Merger, Electronics Entry and Aerospace Orders Drive a Spike of up to 12.4% on 16 November 2026
16 November 2026

Sebi Trading Terminal Rules: What Biometrics, Geotagging and MAC Address Mapping Could Mean for Brokers, Authorised Persons and Traders as the Regulator Targets Terminal Misuse
16 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Kalyan Jewellers Share Price Rally: Stock Gains About 42% in 11 Sessions After Rs 427 Crore Q2 Profit, Hits Near Two-Year High and Trades at Rs 708.15 on 16 November 2026 as UBS and Jefferies Raise Targets
Tata Motors PV vs Eicher Motors After Q2: TMPV Falls 8.7% to Rs 262 on a Rs 5,451 Crore Loss and JLR Guidance Cut While Eicher Posts Record Revenue and a 15% Profit Rise
Belrise Industries Share Price Jumps 9% to Rs 235 After Q2 PAT Rises 25%: Fresh H-One India Merger, Electronics Entry and Aerospace Orders Drive a Spike of up to 12.4% on 16 November 2026
Sebi Trading Terminal Rules: What Biometrics, Geotagging and MAC Address Mapping Could Mean for Brokers, Authorised Persons and Traders as the Regulator Targets Terminal Misuse
Ola Electric vs Ather Energy After Q2: Ather's Rs 1.26 Crore Profit and 63% Revenue Growth Against Ola's Rs 362 Crore Loss and 39% Revenue Fall, and What the Share Prices Imply on 16 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





